The up-regulation profiles of p21WAF1/CIP1 and RUNX1/AML1 correlate with myometrial infiltration in endometrioid endometrial carcinoma

Human Pathology

Volumn 37, Issue 8, 2006, Pages 1050-1057

  Planagumà, Jesús ^a   Gonzalez, Marta ^a   Doll, Andreas ^a   Monge, Marta ^a   Gil Moreno, Antonio ^a,c   Baró, Teresa ^a,c   García, Angel ^a   Xercavins, Jordi ^a,c   Alameda, Francesc ^b,c   Abal, Miguel ^a   Reventós, Jaume ^a,c  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL DEL MAR   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Cell cycle alterations; Endometrioid endometrial carcinoma; Myometrial infiltration; p21WAF1 CIP1; RUNX1 AML1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; TRANSCRIPTION FACTOR RUNX1;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; FEMALE; GENETIC TRANSCRIPTION; GYNECOLOGIC CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; MYOMETRIUM; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; TRANSCRIPTION REGULATION;

CARCINOMA, ENDOMETRIOID; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MYOMETRIUM; NEOPLASM INVASIVENESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 33746074756     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.03.007     Document Type: Article

References (30)

1. Rose P.G. Endometrial carcinoma. N Engl J Med 335 (1996) 640-649
2. Caduff R.F., Svoboda-Neumann S.M., Johnston C.M., Bartos R.E., and Frank T.S. Molecular analysis in endometrial cancer. Verh Dtsch Ges Pathol 81 (1997) 219-227
3. Bokhman J.V. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15 (1983) 10-17
4. Lax S.F., and Kurman R.J. A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses. Verh Dtsch Ges Pathol 81 (1997) 228-232
5. Kurman R.J., and Norris H.J. Blaustein's pathology of the female genital tract (2002), New York, Springer-Verlag
6. Lax S.F. Dualistic model of molecular pathogenesis in endometrial carcinoma. Zentralbl Gynakol 124 (2002) 10-16
7. Salvesen H.B., and Akslen L.A. Molecular pathogenesis and prognostic factors in endometrial carcinoma. Apmis 110 (2002) 673-689
8. Prat J. Prognostic parameters of endometrial carcinoma. Hum Path 35 (2004) 649-662
9. Matias-Guiu X., Catasus L., Bussaglia E., et al. Molecular pathology of endometrial hyperplasia and carcinoma. Hum Path 32 (2001) 569-577
10. Planaguma J., Diaz-Fuertes M., Gil-Moreno A., et al. A differential gene expression profile reveals overexpression of RUNX1/AML1 in invasive endometrioid carcinoma. Cancer Res 64 (2004) 8846-8853
11. Michaud J., Scott H.S., and Escher R. AML1 interconnected pathways of leukemogenesis. Cancer Invest 21 (2003) 105-136
12. Blyth K., Cameron E.R., and Neil J.C. The RUNX genes: gain or loss of function in cancer. Nat Rev Cancer 5 (2005) 376-387
13. Cao W., Britos-Bray M., Claxton D.F., et al. CBF beta-SMMHC, expressed in M4A.M.L. Eo, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells. Oncogene 15 (1997) 1315-1327
14. Lutterbach B., Westendorf J.J., Linggi B., Isaac S., Seto E., and Hiebert S.W. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. J Biol Chem 275 (2000) 651-656
15. Bos R., van Diest P.J., van der Groep P., Shvarts A., Greijer A.E., and van der Wall E. Expression of hypoxia-inducible factor-1 alpha and cell cycle proteins in invasive breast cancer are estrogen receptor related. Breast Cancer Res 6 (2004) R450-R459
16. Skomedal H., Kristensen G.B., Lie A.K., and Holm R. Aberrant expression of the cell cycle associated proteins TP53, MDM2, p21, p27, cdk4, cyclin D1, RB, and EGFR in cervical carcinomas. Gynecol Oncol 73 (1999) 223-228
17. Skomedal H., Kristensen G.B., Nesland J.M., Borresen-Dale A.L., Trope C., and Holm R. TP53 alterations in relation to the cell cycle-associated proteins p21, cyclin D1, CDK4, RB, MDM2, and EGFR in cancers of the uterine corpus. J Pathol 187 (1999) 556-562
18. Bali A., O'Brien P.M., Edwards L.S., Sutherland R.L., Hacker N.F., and Henshall S.M. Cyclin D1, p53, and p21Waf1/Cip1 expression is predictive of poor clinical outcome in serous epithelial ovarian cancer. Clin Cancer Res 10 (2004) 5168-5177
19. Moreno-Bueno G., Rodriguez-Perales S., Sanchez-Estevez C., et al. Cyclin D1 gene (CCND1) mutations in endometrial cancer. Oncogene 22 (2003) 6115-6118
20. Cheng M., Olivier P., Diehl J.A., et al. The p21(Cip1) and p27(Kip1) CDK "inhibitors" are essential activators of cyclin D-dependent kinases in murine fibroblasts. Embo J 18 (1999) 1571-1583
21. LaBaer J., Garrett M.D., Stevenson L.F., et al. New functional activities for the p21 family of CDK inhibitors. Genes Dev 11 (1997) 847-862
22. Strom D.K., Nip J., Westendorf J.J., et al. Expression of the AML-1 oncogene shortens the G(1) phase of the cell cycle. J Biol Chem 275 (2000) 3438-3445
23. Cao Q.J., Einstein M.H., Anderson P.S., Runowicz C.D., Balan R., and Jones J.G. Expression of COX-2, Ki-67, cyclin D1, and P21 in endometrial endometrioid carcinomas. Int J Gynecol Pathol 21 (2002) 147-154
24. Linggi B., Muller-Tidow C., van de Locht L., et al. The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia. Nat Med 8 (2002) 743-750
25. Saegusa M., Hashimura M., Kuwata T., Hamano M., and Okayasu I. Betacatenin of the p53-p21WAF1 pathway and squamous differentiation of endometrial carcinoma cells. Am J Pathol 164 (2004) 1739-1749
26. Nikaido T., Li S.F., Shiozawa T., and Fujii S. Coabnormal expression of cyclin D1 and p53 protein in human uterine endometrial carcinomas. Cancer 78 (1996) 1248-1253
27. Piestrzeniewicz-Ulanska D., Brys M., Semczuk A., Rechberger T., Jakowicki J.A., and Krajewska W.M. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas. Gynecol Oncol 95 (2004) 173-180
28. Theriault F.M., Nuthall H.N., Dong Z., et al. Role for Runx1 in the proliferation and neuronal differentiation of selected progenitor cells in the mammalian nervous system. J Neurosci 25 (2005) 2050-2061
29. Ichikawa M., Asai T., Saito T., et al. AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis. Nat Med 10 (2004) 299-304
30. Fritah A., Saucier C., Mester J., Redeuilh G., and Sabbah M. p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha. Mol Cell Biol 25 (2005) 2419-2430